AZD8797 - 10mM in DMSO, high purity , CAS No.911715-90-7(DMSO)

  • 10mM in DMSO
Item Number
A655834
Grouped product items
SKUSizeAvailabilityPrice Qty
A655834-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$275.90

Basic Description

Specifications & Purity10mM in DMSO
Biochemical and Physiological MechanismsAZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor; antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.
Storage TempStore at -80°C
Shipped InIce chest + Ice pads
Product Description

AZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor; antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.

In Vitro

In a flow adhesion assay, AZD8797 antagonizes the natural ligand, fractalkine (CX3CL1), in both human whole blood (hWB) and in a B-lymphocyte cell line with IC 50 values of 300 and 6 nM respectively. AZD8797 also prevents G-protein activation in a [ 35 S]GTPγS accumulation assay. AZD8797 positively modulates the CX3CL1 response at sub-micromolar concentrations in a β-arrestin recruitment assay. In equilibrium saturation binding experiments, AZD8797 reduces the maximal binding of 125I-CX3CL1 without affecting K d. AZD8797 binds selectively with high affinity to human and rat CX3CR1 (K i of hCX3CR1, 4 nM; K i of rCX3CR1, 7 nM, respectively). The equilibrium dissociation constant, K B , demonstrates that AZD8797 is a very potent inhibitor for human CX3CR1 (10 nM). The potency is threefold lower for rat CX3CR1 (29 nM) and decreases even further at mouse CX3CR1 (54 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

AZD8797 treatment in Dark Agouti rats with myelin oligodendrocyte glycoprotein-induced EAE results in reduced paralysis, CNS pathology, and incidence of relapses. The compound is effective when starting treatment before onset, as well as after the acute phase. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal administration

Rats: AZD8797 is formulated in 30–35% (wt/wt) hydroxy-propyl-beta-cyklodextrin and administered s.c. through osmotic minipumps. Treatment is blinded to the operator. The plasma concentration of AZD8797 is analyzed twice from each rat . aladdin has not independently confirmed the accuracy of these methods. They are for reference only.

Associated Targets(Human)

CX3CR1 Tchem CX3C chemokine receptor 1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Canonical SMILES CC(C)CC(CO)NC1=NC(=NC2=C1SC(=N2)N)SC(C)C3=CC=CC=C3
Molecular Weight 403.56

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

Solution Calculators